|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Haemonetics (NYSE: HAE) through any online brokerage.
The latest price target for Haemonetics (NYSE: HAE) was reported by Morgan Stanley on 2021-04-20. The analyst firm set a price target for 83.00 expecting HAE to rise to within 12 months (a possible 36.00% upside). 18 analyst firms have reported ratings in the last year.
The stock price for Haemonetics (NYSE: HAE) is $61.03 last updated Fri May 07 2021 19:59:54 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Haemonetics.
There is no upcoming split for Haemonetics.